These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8998488)

  • 61. The SF-36 health survey questionnaire: is it suitable for use with older adults?
    Hayes V; Morris J; Wolfe C; Morgan M
    Age Ageing; 1995 Mar; 24(2):120-5. PubMed ID: 7793333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.
    Wu AW; Hays RD; Kelly S; Malitz F; Bozzette SA
    Qual Life Res; 1997 Aug; 6(6):531-54. PubMed ID: 9330553
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Validation and normative data of health status measures in older people: the Islington study.
    Pettit T; Livingston G; Manela M; Kitchen G; Katona C; Bowling A
    Int J Geriatr Psychiatry; 2001 Nov; 16(11):1061-70. PubMed ID: 11746652
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measuring the health of Scottish drug users.
    Neale J
    Health Soc Care Community; 2004 May; 12(3):202-11. PubMed ID: 19777710
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploring the consistency of the SF-6Dv2 in a breast cancer population.
    Ameri H; Safari H; Poder T
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1017-1024. PubMed ID: 33107340
    [No Abstract]   [Full Text] [Related]  

  • 66. Utility and validity of the self-administered SF-36: findings from an older population.
    Chia EM; Chia EM; Rochtchina E; Wang JJ; Mitchell P
    Ann Acad Med Singap; 2006 Jul; 35(7):461-7. PubMed ID: 16902721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SF-36 scores vary by method of administration: implications for study design.
    Lyons RA; Wareham K; Lucas M; Price D; Williams J; Hutchings HA
    J Public Health Med; 1999 Mar; 21(1):41-5. PubMed ID: 10321858
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluate the Quality of Life in Patients With Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft.
    Rahman A; Haider R; Shirin H; Sobhan A; Huq KE
    Cureus; 2024 Jan; 16(1):e52645. PubMed ID: 38380188
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease.
    King SJ; Reid N; Brown SJ; Brodie LJ; Sia ADH; Chatfield MD; Francis RS; Peel NM; Gordon EH; Hubbard RE
    BMC Geriatr; 2023 Oct; 23(1):664. PubMed ID: 37845618
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exploring differences and similarities of EQ-5D-3L, EQ-5D-5L and WHOQOL-OLD in recipients of aged care services in Germany.
    Marten O; Greiner W
    PLoS One; 2023; 18(8):e0290606. PubMed ID: 37624857
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Validation of the Risk Instrument for Screening in the Community (
    O'Caoimh R
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834429
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frailty Screening in the Emergency Department: Comparing the Variable Indicative of Placement Risk, Clinical Frailty Scale and PRISMA-7.
    O'Caoimh R; McGauran J; O'Donovan MR; Gillman C; O'Hea A; Hayes M; O'Connor K; Moloney E; Alcock M
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612612
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of a pay-for-performance program on health-related quality of life for patients with hepatitis in Taiwan.
    Su WC; Chen TT; Yang SS; Shih LN; Liu CK; Wang CC; Wu CH
    Health Qual Life Outcomes; 2022 Sep; 20(1):130. PubMed ID: 36064530
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review.
    Gottschalk S; König HH; Nejad M; Dams J
    Qual Life Res; 2023 Feb; 32(2):307-329. PubMed ID: 35915354
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Psychometric properties of the Czech version of the brief Older People Quality of Life questionnaire (OPQoL-brief).
    Bužgová R; Kozáková R; Zeleníková R; Bobčíková K
    BMC Geriatr; 2022 Jun; 22(1):512. PubMed ID: 35733101
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Feasibility and validity of the EQ-5D-3L in the elderly Europeans: a secondary data analysis using SHARE(d) data.
    Buchholz I; Marten O; Janssen MF
    Qual Life Res; 2022 Nov; 31(11):3267-3282. PubMed ID: 35624409
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age.
    Marten O; Greiner W
    Health Econ Rev; 2022 May; 12(1):28. PubMed ID: 35593942
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using the "Surprise Question" to Predict Frailty and Healthcare Outcomes among Older Adults Attending the Emergency Department.
    Gaffney L; Jonsson A; Judge C; Costello M; O'Donnell J; O'Caoimh R
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162732
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Convergent and Discriminant Validity of the Barthel Index and the EQ-5D-3L When Used on Older People in a Rehabilitation Setting.
    Kaambwa B; Bulamu NB; Mpundu-Kaambwa C; Oppong R
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Feasibility of the EQ-5D in the elderly population: a systematic review of the literature.
    Marten O; Brand L; Greiner W
    Qual Life Res; 2022 Jun; 31(6):1621-1637. PubMed ID: 34613597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.